RGT 0.00% 30.5¢ argent biopharma limited

Panax acquisition well advanced,- we are near completion of this key acquisition, page-86

  1. 5,991 Posts.
    lightbulb Created with Sketch. 101
    A comment made by NS, sounds promising

    Nativ Segev: There are many reasons why MXC is focusing on Australia, both as a large market for our products (cosmetics, supplements, medicinal), but also as an operational base of growing, production and manufacturing for the entire southern hemisphere including the Asia- Pacific market (Thailand, China, Japan, etc).

    Furthermore, we are listed here, so we have a strong desire and responsibility to serve our home market; we are big believers in being first to market and being leaders in the Australian market.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.